These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24826489)

  • 21. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the potential for gender bias in the prediction of symptom validity test failure by MMPI-2 symptom validity scale scores.
    Lee TT; Graham JR; Sellbom M; Gervais RO
    Psychol Assess; 2012 Sep; 24(3):618-27. PubMed ID: 22309000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of the post-concussive symptom questionnaire.
    Van Dyke SA; Axelrod BN; Schutte C
    Arch Clin Neuropsychol; 2010 Nov; 25(7):634-9. PubMed ID: 20710017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Lees-Haley Fake Bad Scale, Henry-Heilbronner Index, and restructured clinical scale 1 in identifying noncredible symptom reporting.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C; Stanczak SR
    Clin Neuropsychol; 2008 Sep; 22(5):919-29. PubMed ID: 18756392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting malingered and defensive responding on the MMPI-2 in a forensic inpatient sample.
    Bagby RM; Rogers R; Buis T
    J Pers Assess; 1994 Apr; 62(2):191-203. PubMed ID: 8189330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fake bad scale in atypical and severe closed head injury litigants.
    Greiffenstein MF; Baker WJ; Gola T; Donders J; Miller L
    J Clin Psychol; 2002 Dec; 58(12):1591-600. PubMed ID: 12455024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparative capacity of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2 Restructured Form (MMPI-2-RF) validity scales to detect suspected malingering in a disability claimant sample.
    Chmielewski M; Zhu J; Burchett D; Bury AS; Bagby RM
    Psychol Assess; 2017 Feb; 29(2):199-208. PubMed ID: 27183046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does True Neurocognitive Dysfunction Contribute to Minnesota Multiphasic Personality Inventory-2nd Edition-Restructured Form Cognitive Validity Scale Scores?
    Martin PK; Schroeder RW; Heinrichs RJ; Baade LE
    Arch Clin Neuropsychol; 2015 Aug; 30(5):377-86. PubMed ID: 26051870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
    Tsushima WT; Geling O; Fabrigas J
    Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the Malingering Discriminant Function Index for the MMPI-2.
    Bacchiochi JR; Bagby RM
    J Pers Assess; 2006 Aug; 87(1):51-61. PubMed ID: 16856786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance.
    Staudenmayer H; Phillips S
    J Psychosom Res; 2007 Jan; 62(1):61-72. PubMed ID: 17188122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Fake Bad Scale and MMPI-2 F-family in detection of implausible psychological trauma claims.
    Greiffenstein MF; Baker WJ; Axelrod B; Peck EA; Gervais R
    Clin Neuropsychol; 2004 Dec; 18(4):573-90. PubMed ID: 15841958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMPI-2 restructured form over-reporting scales in first-episode psychosis.
    Purdon SE; Purser SM; Goddard KM
    Clin Neuropsychol; 2011 Jul; 25(5):829-42. PubMed ID: 21756212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of the new MMPI-2 Malingered Depression scale to individuals undergoing neuropsychological evaluation: relative lack of relationship to secondary gain and failure on validity indices.
    Sweet JJ; Malina A; Ecklund-Johnson E
    Clin Neuropsychol; 2006 Sep; 20(3):541-51. PubMed ID: 16895865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessing the validity and reliability of the MMPI Alexithymia Scale.
    Bagby RM; Parker JD; Taylor GJ
    J Pers Assess; 1991 Apr; 56(2):238-53. PubMed ID: 2056419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.